Heterogeneous burden of lung disease in smokers with borderline airflow obstruction

Abstract Background The identification of smoking-related lung disease in current and former smokers with normal FEV1 is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) of less than 0.70 versus the predicted lower limit of nor...

Full description

Bibliographic Details
Main Authors: Cheryl S. Pirozzi, Tian Gu, Pedro M. Quibrera, Elizabeth E. Carretta, MeiLan K. Han, Susan Murray, Christopher B. Cooper, Donald P. Tashkin, Eric C. Kleerup, Igor Barjaktarevic, Eric A. Hoffman, Carlos H. Martinez, Stephanie A. Christenson, Nadia N. Hansel, R. Graham Barr, Eugene R. Bleecker, Victor E. Ortega, Fernando J. Martinez, Richard E. Kanner, Robert Paine, for the NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Respiratory Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12931-018-0911-z
_version_ 1828758797041008640
author Cheryl S. Pirozzi
Tian Gu
Pedro M. Quibrera
Elizabeth E. Carretta
MeiLan K. Han
Susan Murray
Christopher B. Cooper
Donald P. Tashkin
Eric C. Kleerup
Igor Barjaktarevic
Eric A. Hoffman
Carlos H. Martinez
Stephanie A. Christenson
Nadia N. Hansel
R. Graham Barr
Eugene R. Bleecker
Victor E. Ortega
Fernando J. Martinez
Richard E. Kanner
Robert Paine
for the NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)
author_facet Cheryl S. Pirozzi
Tian Gu
Pedro M. Quibrera
Elizabeth E. Carretta
MeiLan K. Han
Susan Murray
Christopher B. Cooper
Donald P. Tashkin
Eric C. Kleerup
Igor Barjaktarevic
Eric A. Hoffman
Carlos H. Martinez
Stephanie A. Christenson
Nadia N. Hansel
R. Graham Barr
Eugene R. Bleecker
Victor E. Ortega
Fernando J. Martinez
Richard E. Kanner
Robert Paine
for the NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)
author_sort Cheryl S. Pirozzi
collection DOAJ
description Abstract Background The identification of smoking-related lung disease in current and former smokers with normal FEV1 is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV1/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group. Methods We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV1 and FEV1/FVC > 0.70 in the SPIROMICS cohort. We also estimated sensitivity and specificity for diagnosing objective radiographic evidence of chronic obstructive pulmonary disease (COPD) using different FEV1/FVC criteria thresholds. Results The discordant group had more CT defined emphysema and non-emphysematous gas trapping, lower post-bronchodilator FEV1 and FEF25–75, and higher respiratory medication use compared with the other two groups. Within the discordant group, 44% had radiographic CT evidence of either emphysema or non-emphysematous gas trapping; an FEV1/FVC threshold of 0.70 has greater sensitivity but lower specificity compared with LLN for identifying individuals with CT abnormality. Conclusions Ever-smokers with normal FEV1 and FEV1/FVC <  0.70 but > LLN are a heterogeneous group that includes significant numbers of individuals with and without radiographic evidence of smoking-related lung disease. These findings emphasize the limitations of diagnosing COPD based on spirometric criteria alone.
first_indexed 2024-12-11T00:47:25Z
format Article
id doaj.art-813295b24fab4c7182e5ff9b1d3ac7b9
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-12-11T00:47:25Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-813295b24fab4c7182e5ff9b1d3ac7b92022-12-22T01:26:43ZengBMCRespiratory Research1465-993X2018-11-0119111010.1186/s12931-018-0911-zHeterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S. Pirozzi0Tian Gu1Pedro M. Quibrera2Elizabeth E. Carretta3MeiLan K. Han4Susan Murray5Christopher B. Cooper6Donald P. Tashkin7Eric C. Kleerup8Igor Barjaktarevic9Eric A. Hoffman10Carlos H. Martinez11Stephanie A. Christenson12Nadia N. Hansel13R. Graham Barr14Eugene R. Bleecker15Victor E. Ortega16Fernando J. Martinez17Richard E. Kanner18Robert Paine19for the NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of UtahDepartment of Biostatistics, University of MichiganDepartment of Biostatistics, Collaborative Studies Coordinating Center, University of North Carolina at Chapel HillDepartment of Biostatistics, Collaborative Studies Coordinating Center, University of North Carolina at Chapel HillDepartment of Internal Medicine, University of MichiganDepartment of Biostatistics, University of MichiganDepartment of Medicine, UCLA David Geffen School of MedicineDepartment of Medicine, UCLA David Geffen School of MedicineDepartment of Medicine, UCLA David Geffen School of MedicineDepartment of Medicine, UCLA David Geffen School of MedicineDepartment of Radiology, University of IowaDepartment of Biostatistics, University of MichiganDepartment of Medicine, University of CaliforniaDepartment of Medicine, Johns Hopkins UniversityDepartment of Medicine, Columbia UniversityDepartment of Medicine, University of ArizonaDepartment of Medicine, Wake Forest UniversityDepartment of Medicine, Weill Cornell Medical CollegeDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of UtahDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of UtahAbstract Background The identification of smoking-related lung disease in current and former smokers with normal FEV1 is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV1/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group. Methods We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV1 and FEV1/FVC > 0.70 in the SPIROMICS cohort. We also estimated sensitivity and specificity for diagnosing objective radiographic evidence of chronic obstructive pulmonary disease (COPD) using different FEV1/FVC criteria thresholds. Results The discordant group had more CT defined emphysema and non-emphysematous gas trapping, lower post-bronchodilator FEV1 and FEF25–75, and higher respiratory medication use compared with the other two groups. Within the discordant group, 44% had radiographic CT evidence of either emphysema or non-emphysematous gas trapping; an FEV1/FVC threshold of 0.70 has greater sensitivity but lower specificity compared with LLN for identifying individuals with CT abnormality. Conclusions Ever-smokers with normal FEV1 and FEV1/FVC <  0.70 but > LLN are a heterogeneous group that includes significant numbers of individuals with and without radiographic evidence of smoking-related lung disease. These findings emphasize the limitations of diagnosing COPD based on spirometric criteria alone.http://link.springer.com/article/10.1186/s12931-018-0911-zChronic obstructive pulmonary diseasePulmonary function testsSpirometryAirway obstructionEmphysemaForced expiratory volume
spellingShingle Cheryl S. Pirozzi
Tian Gu
Pedro M. Quibrera
Elizabeth E. Carretta
MeiLan K. Han
Susan Murray
Christopher B. Cooper
Donald P. Tashkin
Eric C. Kleerup
Igor Barjaktarevic
Eric A. Hoffman
Carlos H. Martinez
Stephanie A. Christenson
Nadia N. Hansel
R. Graham Barr
Eugene R. Bleecker
Victor E. Ortega
Fernando J. Martinez
Richard E. Kanner
Robert Paine
for the NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
Respiratory Research
Chronic obstructive pulmonary disease
Pulmonary function tests
Spirometry
Airway obstruction
Emphysema
Forced expiratory volume
title Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
title_full Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
title_fullStr Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
title_full_unstemmed Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
title_short Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
title_sort heterogeneous burden of lung disease in smokers with borderline airflow obstruction
topic Chronic obstructive pulmonary disease
Pulmonary function tests
Spirometry
Airway obstruction
Emphysema
Forced expiratory volume
url http://link.springer.com/article/10.1186/s12931-018-0911-z
work_keys_str_mv AT cherylspirozzi heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT tiangu heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT pedromquibrera heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT elizabethecarretta heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT meilankhan heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT susanmurray heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT christopherbcooper heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT donaldptashkin heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT ericckleerup heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT igorbarjaktarevic heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT ericahoffman heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT carloshmartinez heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT stephanieachristenson heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT nadianhansel heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT rgrahambarr heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT eugenerbleecker heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT victoreortega heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT fernandojmartinez heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT richardekanner heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT robertpaine heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction
AT forthenhlbisubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics heterogeneousburdenoflungdiseaseinsmokerswithborderlineairflowobstruction